Similarly, some studies have described CD19+ B cells as the pathogenic populations within lung tumors (Tumor-infiltrating B cells: their role and application in anti-tumor immunity in lung cancer, Bal T lymphocyte subsets are reduced in primary lung neoplasias) (Wang et al., 2019; Cascio et al., 1993). Here, CD19 is linked to neoplasm.